What question did this study set out to answer?

This research aims to understand the role of regulatory T cells in breast cancer brain metastasis and their effect on microglial function.

April 19, 2026

Abstract LB087: Regulatory T cells control anti-tumor microglia function in breast cancer brain metastasis

Key Points

This research aims to understand the role of regulatory T cells in breast cancer brain metastasis and their effect on microglial function.
Investigated Treg infiltration in the brain using animal models of breast cancer brain metastasis.
Examined the effects of systemic and localized Treg depletion on antitumor immune responses.
Analyzed interactions between Tregs and microglia at the tumor-stroma interface.
Treg depletion led to increased T cell accumulation and complete clearance of brain metastases.
Microglia exhibited enhanced antigen presentation capabilities post-Treg depletion.
Microglia depletion reversed tumor clearance effects following Treg loss and reduced T cell infiltration.

Abstract

Abstract Breast cancer brain metastasis (BCBM) is linked with dismal outcomes. Current therapies fail due to their inability to cross the blood-brain barrier (BBB). Targeting immune cells in BCBM has garnered interest since immune cells naturally cross the BBB. Thus, there is a critical need to elucidate the immune microenvironment within BCBM. Regulatory T cells (Tregs) are immunosuppressive T cells implicated in several malignancies. However, their functions remain poorly understood in BCBM. Here we demonstrate that Tregs readily infiltrate the brain and suppress microglial responses to BCBM. Systemic Treg depletion in BCBM-bearing mice led to a massive accumulation of T cells and complete clearance of metastasis. We also found that microglia displayed a robust antigen presentation phenotype in Treg-depleted mice. Localized Treg depletion in the brain resulted in preferential expansion of conventional CD4 T cells (Tconv) 24h after Treg depletion and enrichment of antigen presentation in microglia at 48h. In situ analysis showed that Tregs and microglia co-localize at the tumor-stroma interface, indicating crosstalk between these two populations. Strikingly, microglia depletion reversed tumor clearance after Treg loss and significantly reduced Tconv infiltration. Preliminary analysis of available scRNAseq data of human brain metastases and mouse BCBM samples suggests that Treg-mediated suppression of microglia occurs through TIGIT-NECTIN2 signaling. Our data demonstrates that Tregs are central to BCBM progression through suppression of microglial antigen presentation and effector T cell responses. These findings identify Treg-mediated suppression of microglia as a central axis of immunosuppression in BCBM and a promising immunotherapeutic target. Citation Format: Isam Adam, Pascal Naef, Erika Zagni, Aaron Longworth, Hannah Savage, Jacob Insua-Rodriguez, Noah Wechter, Lincy Antony, Timothy McMullen, Eva Zhao, Francesco Marangoni, Devon Lawson. Regulatory T cells control anti-tumor microglia function in breast cancer brain metastasis abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts) ; 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86 (8Suppl): Abstract nr LB087.

Mark Helpful

Bookmark

Relay